BlackRock
AST.WS

BlackRock’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

BlackRock’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,856
Closed -$1K – 5170
2017
Q2 		$1K Hold
2,856
– – ﹤0.01% 5011
2017
Q1 		$1K Buy
+2,856
New +$1.05K ﹤0.01% 5004

BlackRock's AST.WS Position: Q3 2017 in Review

BlackRock sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 2,856 shares — an estimated $1K sold.

BlackRock first reported a position in AST.WS in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • BlackRock reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • BlackRock sold 2,856 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $1K.
  • BlackRock first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q1 2017 and held it in 2 quarters.
  • BlackRock's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $1K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on BlackRock's 13F filing for Q3 2017, filed 14 Nov 2017.